Details.
Detects residual tumour cells below the limit of morphological detection using flow cytometric immunofluorescence of surface markers. A panel of at least three antibodies is selected based on the immunophenotype of the original leukaemia.
at Cytoquest Corporation · Toronto
Detects residual tumour cells below the limit of morphological detection using flow cytometric immunofluorescence of surface markers. A panel of at least three antibodies is selected based on the immunophenotype of the original leukaemia.
Get the app to book and see what else is on nearby.